Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Chronic Obstuctive Pulmonary Disease Clinical Trial
Lung Microbiome and Inflammation in Early COPD
Status: Enrolling, Phase
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Cystic Fibrosis (CF) Clinical Trial
Evaluation Of The Pan-microbiome and Host Immune Response in CF
Status: Enrolling, Phase
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Acthar SLE (Systemic Lupus Erythematosus)
Status: Enrolling, Phase IV
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Carotid Occlusion Clinical Trial
STAMCAR: A Prospective EC-IC Bypass Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Lahey Hospital and Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
SUNY College of Optometry
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Norton Neurology Services
mi
from
Louisville, KY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Neurological Services Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling, Phase III
Updated: 4/25/2018
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling, Phase III
Updated: 4/25/2018
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling, Phase III
Updated: 4/25/2018
University of Kansas
mi
from
Fairway, KS
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling, Phase III
Updated: 4/25/2018
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling, Phase III
Updated: 12/31/1969
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling, Phase III
Updated: 12/31/1969
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Enteral Feeding Clinical Trial
Tolerance of a Calorically Dense Enteral Nutrition Formula
Status: Enrolling
Updated: 6/29/2016
OUHSC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Advanced or Metastatic ER+ Breast Cancer Clinical Trial
Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Children's Hospital Brain Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter Health Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Clinical Trial
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
Status: Enrolling
Updated: 12/31/1969
ECOG-ACRIN Cancer Research Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
The Effects of Bariatric Surgeries on Glucose Metabolism
Status: Enrolling, Phase
Updated: 12/31/1969
South Texas Veterans Health Care System
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
Status: Enrolling, Phase II
Updated: 12/31/1969
Blood and Marrow Transplant Group of Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Carle on Vermilion
mi
from
Danville, IL
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
SCL Health Saint Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Essentia Health Cancer Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Greer
mi
from
Greer, SC
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Carle Physician Group-Mattoon/Charleston
mi
from
Mattoon, IL
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Spartanburg
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Smilow Cancer Hospital-Waterbury Care Center
mi
from
Waterbury, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Greenville Health System Cancer Institute
mi
from
Greenville, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Status: Enrolling, Phase I
Updated: 12/31/1969
UMass Memorial Medical Center - university campus
mi
from
Worcester, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
John Hopkins Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
Seattle Rheumatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Treatments Against RA and Effect on FDG-PET/CT
Status: Enrolling, Phase IV
Updated: 12/31/1969
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Click here to add this to my saved trials
Anal High-Grade Squamous Intraepithelial Lesions Clinical Trial
Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Diabetic Chronic Kidney Disease Clinical Trial
A Study of Autologous Neo-Kidney Augment™ (NKA) in Type 2 Diabetics With Chronic Kidney Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Diabetic Chronic Kidney Disease Clinical Trial
A Study of Autologous Neo-Kidney Augment™ (NKA) in Type 2 Diabetics With Chronic Kidney Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Arizona Cancer Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford University
mi
from
Redwood City, CA
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hereditary Breast and Ovarian Cancer Syndrome Clinical Trial
The Women Choosing Surgical Prevention (WISP) Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Hereditary Breast and Ovarian Cancer Syndrome Clinical Trial
The Women Choosing Surgical Prevention (WISP) Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Neurologists of Southern Ct., PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
West Cancer Center
mi
from
Germantown, TN
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology
mi
from
Plano, TX
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence St. Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University
mi
from
Washington DC,
Click here to add this to my saved trials
Gastrointestinal Tolerance Clinical Trial
Effect of Formula on Infant Behavior
Status: Enrolling
Updated: 7/20/2016
Southeastern Pediatric Associates
mi
from
Dothan, AL
Click here to add this to my saved trials
Gastrointestinal Tolerance Clinical Trial
Effect of Formula on Infant Behavior
Status: Enrolling
Updated: 7/20/2016
Watching Over Mothers & Babies
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
North Star Lodge
mi
from
Yakima, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Women's Cancer Care Associates
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Katmai Oncology Group
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Alaska Women's Cancer Care
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Augusta University Medical Center
mi
from
Augusta, GA
Click here to add this to my saved trials